C. Duba

A randomized study comparing interferon (IFNα) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML)

Thomas Kühr, Sonja Burgstaller, Ute Apfelbeck et al. · Leukemia Research · 2003 · 25 citations

Medicine, Hematology, Oncology +14

Interferon alpha-2c therapy of patients with chronic myelogenous leukemia: long-term results of a multicenter phase-II study

J. Thaler, Guenther Gastl, Thomas Fluckinger et al. · Annals of Hematology · 1996 · 18 citations

Medicine, Hematology, Oncology +10

Bone marrow lymphocyte subsets in myelodysplastic syndromes.

Wolfgang Hilbe, Wolfgang Eisterer, Christopher H. Schmid et al. · Journal of Clinical Pathology · 1994 · 16 citations · Full text

Medicine, Hematology, Pathology +17

Treatment of patients with advanced chronic myelogenous leukemia with interferon-alpha-2b and continuous oral cytarabine ocfosfate (YNK01):

Thomas Kühr, Wolfgang Eisterer, Ute Apfelbeck et al. · Leukemia Research · 2000 · 14 citations

Medicine, Oncology, Pharmacotherapy +13

Treatment of 11 patients with chronic myelogenous leukemia with interferon-alpha-2C and low-dose cytosine arabinoside

J. Thaler, Thomas Fluckinger, H. Huber et al. · Leukemia Research · 1993 · 12 citations

Medicine, Hematology, Oncology +11